ABSTRACT Background. Racial disparities in outcomes have been documented among patients with esophageal cancer. The purpose of this study is to identify mechanisms for ethnicity/race-related differences in the use of cancer-directed surgery and mortality. Methods. Data from the Surveillance, Epidemiology and End Results (SEER) program were used to evaluate nonHispanic black, non-Hispanic white and Hispanic patients diagnosed with non-metastatic esophageal cancer (squamous cell carcinoma or adenocarcinoma) from [2003][2004][2005][2006][2007][2008]. Age, marital status, stage, histology and location were examined as predictors of receipt of surgery and mortality in multivariate analyses. Results. A total of 6,737 patient files (84 % white, 10 % black, 6 % Hispanic) were analyzed. Black and Hispanic patients were more likely than whites to have squamous cell carcinoma (86 vs. 41 vs. 26 %, respectively; p \ 0.001) and lesions in the midesophagus (58 vs. 38 vs. 26 %, respectively; p \ 0.001). Blacks and Hispanics were less likely to undergo esophagectomy (adjusted odds ratio 0.48, 95 % confidence interval (CI) 0.39-0.60 and 0.71, 95 % CI 0.56-0.90]. We noted significant variations in esophagectomy rates among patients with midesophageal cancers; 15 % of blacks underwent esophagectomy compared to 22 % of Hispanics and 29 % of whites (p \ 0.001). Black and Hispanic patients had a higher unadjusted risk of mortality (hazard ratio 1.38, 95 % CI 1.25-1.52 and 1.20, 95 % CI 1.05-1.37). However, differences in mortality were no longer significant after adjusting for receipt of surgery. Conclusions. Disparities in esophageal cancer outcomes are associated with the lower use of cancer-directed surgery. To decrease disparities in mortality it will be necessary to understand and target underlying causes of lower surgery rates in nonwhite patients and develop interventions, especially for midesophageal cancers.
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The incidence of esophageal cancer has been increasing over the past two decades with over 17,000 new diagnoses and over 15,000 deaths in the United States annually. 1 Overall, advances in multimodal treatment, including chemotherapy, radiation and surgical techniques have improved esophageal cancer outcomes. However, not all populations have benefited from these treatment strategies, and survival continues to be poorer among minority patients. [2] [3] [4] [5] Nationally, the 5-year survival in black patients with localized esophageal cancer is 21.3 % compared to 39.6 % in whites. 6 Although the racial and ethnic disparity in esophageal cancer outcomes has been well documented, the underlying mechanisms are not well described.
Race-and ethnicity-related variation in the receipt of evidence based processes of care is a common explanation for disparate outcomes. [7] [8] [9] For many cancer types, race and ethnicity are significant predictors of nonoperative management among patients with potentially resectable tumors. 7, [10] [11] [12] Lower socioeconomic status, higher burden of comorbid conditions, and differential access to surgical specialists have been associated with failure to undergo cancer-directed surgery. 13 However, accounting for patient level factors and access-related issues have failed to fully explain the underuse of surgical resection and the excess mortality observed in nonwhite patients with esophageal cancer. 3 The purpose of this study was to identify underlying mechanisms of racial and ethnic disparities in esophageal cancer treatment and outcomes. First, we explored the relationship between race, ethnicity and the receipt of cancer-directed surgery while adjusting for patient and tumor factors. Second, we examined the roles of race, ethnicity and cancer directed-surgery in overall survival.
METHODS

Data
We used the Surveillance Epidemiology and End Results (SEER) database of the National Cancer Institute to identify the study cohort. The SEER 17 program of the National Cancer Institute is a cancer-specific database that contains patient demographics and information related to tumor stage, location and surgical treatment. At the time of the study, SEER registries covered eleven states, and seven county-based areas within an additional three states, and represented 28 % of the United States population. This population-based cohort is considered a representative racial and socioeconomic sample of the United States. 9 
Study Population
We identified non-Hispanic black, non-Hispanic white, and Hispanic patients ages 18-85 who were diagnosed with local and regional (nonmetastatic) esophageal cancer between January 1, 2003 and December 31, 2008. Patients with squamous cell (SCC) and adenocarcinoma, histologies which comprise 95 % of all esophageal cancers, were included. Patients with distal and mid esophageal cancers were included in the analysis. Surgical resection, either alone or combined with chemoradiation, is the preferred treatment for this population. Patients with cervical (proximal) cancers were excluded, because surgery is rarely indicated (n = 817). Patients were also excluded if they had histology other than SCC or adenocarcinoma (n = 1,214). Patients with an unknown surgical status were also excluded from the analysis (n = 64).
Study Variables
The primary exposure variable was non-Hispanic black, non-Hispanic white or Hispanic ethnicity/race. The primary outcome of the study was receipt of cancer-directed surgery (esophagectomy), as coded in the International Classification of Disease, 9th revision, Clinical Modification (ICD-9-CM). Palliative, local ablative and/or diagnostic procedures were not included in the definition of cancer-directed surgery. The secondary outcome was mortality obtained from the SEER files. Patient demographics (age at diagnosis, gender and marital status) and tumor characteristics (stage, location and histology) were included in the analysis.
Statistical Analysis
Univariate analysis, performed with the chi-square test for categorical variables and analysis of variance for continuous variables, was used to compare racial and ethnic differences in patient demographics and tumor characteristics. We used logistic regression to evaluate the relationship between race, ethnicity and receipt of cancer-directed surgery. The model was adjusted for patient and tumor characteristics as potential confounders.
Cox proportional hazards regression was used to evaluate the relationship between race, ethnicity and mortality. The model was sequentially adjusted for patient factors, tumor factors and receipt of cancer-directed surgery. Survival time was calculated as the numbers of days from cancer diagnosis until death. Patients who were alive after December 31, 2008 were censored.
All tests of statistical significance were two-sided, and statistical significance was defined as p B 0.05. All analyses were performed with Stata 12 (StataCorp, College Station, TX). This project was exempt from institutional review board examination.
RESULTS
Patient Characteristics
The analytic cohort consisted of 6,737 patients. Among these, 5,652 were non-Hispanic white, 700 non-Hispanic black and 385 Hispanic. Black patients were significantly younger at the time of diagnosis compared to Hispanic and white patients (63.7 vs. 66.1 vs. 67.2 years of age, p \ 0.001, respectively), and black patients were more likely to be single at the time of diagnosis (p \ 0.001; Table 1 ). We identified significant racial differences in tumor histology and location (Table 1) ; however, there were no racial or ethnic differences in cancer stage at the time of diagnosis. Black and Hispanic patients were considerably more likely to have SCC histology compared to white patients (85.9 vs. 40.8 vs. 26.1 %, respectively p \ 0.001; Table 1 ). Black and Hispanic patients were also more likely to have midesophageal cancers compared to whites (58.1 vs. 37.7 vs. 21.4 %, p \ 0.001; Table 1 ). Overall, there was a significant relationship between histology and tumor location with 61.1 % of squamous cell cancers located in the midesophagus compared to 8.8 % of adenocarcinomas (p \ 0.001; Table 2 ).
Use of Cancer-Directed Surgery
The unadjusted odds of undergoing esophagectomy were significantly lower for black and Hispanic patients, compared to whites [odds ratio (OR) 0.33, 95 % confidence interval (CI) 0.28-0.40 and OR 0.67, 95 % CI 0.55-0.84, respectively; Table 3 ]. After adjusting for patient and tumor characteristics, black and Hispanic patients remained significantly less likely to undergo an esophagectomy (OR 0.48, 95 % CI 0.39-0.60 and OR 0.71, 95 % CI 0.56-0.90, respectively; Table 3 ). Regardless of race or ethnicity, the odds of surgical resection were significantly lower in patients with SCC (OR 0.57, 95 % CI 0.49-0.65), and patients with cancers located in the midesophagus (OR 0.58, 95 % CI 0.50-0.67).
We also noted an ethnicity/race effect within tumor location and histology categories (Fig. 1) . Rates of resection for patients with midesophageal cancers were low for all three race/ethnicity groups with both SCC and adenocarcinoma; however differences were particularly pronounced among black patients with adenocarcinoma. Only 15 % of black patients with midesophageal cancers underwent esophagectomy compared to 23 % of Hispanics and 28.9 % of whites (p \ 0.001; Fig. 2) . The difference is slightly less pronounced for patients with distal esophageal cancers; 32.4 % of blacks underwent cancer-directed surgery compared to 45 % of Hispanics and 50.8 % of whites (p \ 0.001; Fig. 2 ). Relationship Between Race, Ethnicity, and Mortality Black and Hispanic patients had a significantly higher unadjusted hazard of mortality than whites [hazard ratio (HR) = 1.38, 95 % CI 1.25-1.52 and HR 1.20, 95 % CI 1.05-1.37, respectively; Table 4 ]. After controlling for patient and tumor characteristics, racial and ethnic differences in mortality remained significant (HR 1.13, 95 % CI 1.01-1.26 and HR 1.17, 95 % CI 1.03-1.34, respectively; Table 4 ). However, differences in mortality were no longer apparent after accounting for the receipt of cancer-directed surgery.
DISCUSSION
Using population-based data, we demonstrated race-and ethnicity-related variation in esophageal cancer histology and location. Nonwhite patients were significantly more likely to have tumors with squamous cell histology and tumors located in the middle esophagus compared to white patients. Moreover, we found that resection rates varied widely based upon race, ethnicity, histology and tumor location. Nonwhite race, SCC histology and midesophageal cancer location were independent predictors of nonoperative management. As a result, racial-and ethnicity-related disparities in resection rates were much more pronounced in black and Hispanic patients due the preponderance of SCC histology and midesophageal lesions. The underuse of cancer-directed surgery in nonwhite patients contributed to higher mortality rates among this population.
Consistent with published reports we found a preponderance of SCC histology among minority patients. 14, 15 Risk factors for SCC are different from those related to adenocarcinoma and include sources of chronic irritation, inflammation and oxidative damage. Related behavioral risk factors for SCC, such as diets low in fresh fruits and vegetables, diets high in red meat, micronutrient deficiencies and heavy alcohol and tobacco use, are widely correlated with low socioeconomic status. 16, 17 We confirmed a strong relationship between tumor histology and tumor location. Overall, SCC cancers were significantly more likely to be located in the middle esophagus while adenocarcinoma was more likely to be identified in distal esophagus. Our findings are consistent with historical trends, as the incidence of adenocarcinoma correlates with the increasing incidence of distal-esophageal tumors. 2, 18 In addition, we found that esophagectomy rates varied independently by race/ethnicity, histology, and tumor location. Prior studies have described race-related disparities in esophagectomy rates; however, the underlying processes were not well delineated. Separate analyses of the SEER and SEER-Medicare databases, have shown that surgery is underutilized among black patients with potentially resectable esophageal cancer. 5, [7] [8] [9] [10] The current study confirms that resection rates are lower among nonwhite patients. It is plausible that disparities in resection rates are more pronounced in black and Hispanic patients because of the higher proportion of SCC and therefore midesophageal tumors among these groups. Nonwhite patients may have decreased access to centers with sufficient volume and experience with the complex operations required for 19 Granular examination of physician attitudes, behaviors and referral patterns may inform how to change practice patterns and assure that nonwhite patients are referred to surgeons for appropriate management.
Finally, previous studies have documented racial differences in the health outcomes of patients with esophageal cancer. 2, 4, 5, 10 We found that there were no race/ethnicityassociated differences in tumor stage and that disparities in survival disappeared after adjusting for receipt of esophagectomy. Taken together, these findings imply that underuse of cancer-directed surgery in nonwhite patients contributes substantially to higher mortality rates.
We must acknowledge that racial and ethnicity-related differences in the use of potentially life-saving surgery persisted even after accounting for tumor histology and location illustrating that disparities in resection rates are in fact multifactorial. Previous studies have reported that nonwhite patients were substantially less likely to go to the operating room despite risk-adjustment for patient, tumor and hospital level characteristics. 8, 9, 20 Disparities in resection rates and survival may also be related to the quality of care received and race-related differences in the patient-physician relationship and systems-based coordination of care issues. 8, 21 These issues must be clarified to better understand underlying causes for low esophagectomy rates in nonwhite patients with potentially resectable disease.
Our study had several limitations which must be noted. First, our data set did not include important patient-level determinants of cancer survival including comorbidities, patient-level socioeconomic status, insurance coverage, information regarding the treating facilities, or information about the use of systemic therapies. Important patient and hospital level characteristics may preclude cancer resection such as coexisting illnesses or lack of access to specialists, which deserves further investigation as a potential area for intervention. Second, the study does not address patientphysician interactions or provide information regarding racial variation in treatment decision making. Patientphysician relationships are no doubt crucial to provision of care and the current data support further study of these mechanisms.
In summary, using population-based data, we demonstrate that race and ethnicity are associated with esophageal cancer histology and location, which in turn are related to cancer-directed surgery. The use of cancer-directed surgery is associated with longer overall survival in patients with early stage esophageal cancer and we have shown that racial and ethnic differences in esophageal cancer survival are ameliorated after controlling for receipt of cancerdirected surgery. The failure of nonwhites to undergo cancer-directed surgery is an important public health and policy issue. To decrease disparities in esophageal cancer outcomes, it will be necessary to better understand underlying causes for low esophagectomy rates in nonwhite patients and to develop interventions that improve curative surgery rates for midesophageal cancer. 
